Immunotherapy Weekly articles from June 2002

Immunotherapy Weekly archives from June 2002

Researchers seek new hope in old treatment.(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Theophylline, an asthma medication prescribed since the 1970s, is now being studied for new potential merits. The Effectiveness of Low Dose Theophylline as Add-On Therapy in the Treatment of Asthma...

Heartburn surgery helps lung transplant patients.(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Duke University Medical Center researchers have found that a surgical procedure used to treat chronic heartburn appears not only to improve the functioning of transplanted lungs but also has a positive...

RAGE protein worsens arthritis.(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Different types of a protein called RAGE may explain why rheumatoid arthritis cripples some people yet leaves others only mildly affected, new research reveals in the journal Genes and Immunity. ...

CDC reports asthma still a problem for millions.(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Asthma remains a major public health problem in the United States despite some evidence that death rates have leveled off and hospitalization rates have declined. In 1999, an estimated 26.7 million...

Immunosuppressive therapy with Prograf reduces rejection risk in pediatric liver transplant patients.(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Pediatric patients receiving liver transplants are less likely to suffer acute rejection if they receive immunosuppressive therapy based on Prograf (tacrolimus), as opposed to ciclosporin microemulsion....

Bioption, IAVI partnering to develop globally accessible AIDS vaccines.(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Swedish biotechnology firm Bioption AB is partnering with the International AIDS Vaccine Initiative (IAVI) to develop and test a new approach for vaccines that can train the immune system to protect...

Research: Common acne antibiotic minocycline delays progression of ALS.(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Project A.L.S.-funded researchers at Brigham and Women's Hospital (BWH) have identified the process in which the antibiotic minocycline, commonly prescribed for acne, inhibits the progression of cell...

Company completes discovery phase of target identification collaboration.(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Rigel Pharmaceuticals, Inc., (RIGL) announced that it has delivered six additional validated drug targets to Pfizer, Inc., (PFE) thereby completing its discovery phase respiratory disease research...

Orchid enters pharmacogenomics collaboration with Merck-Medco.(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Orchid BioSciences, Inc., (ORCH) announced a pharmacogenomics collaboration between its Orchid GeneShield strategic business unit and Merck-Medco, a subsidiary of Merck & Co., Inc., (MRK). Under...

Reducing AEDs in patients using VNS therapy doesn't impair effectiveness in controlling seizures.(antiepileptic drugs; vagus nerve stimulation)(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Reducing the number of antiepileptic drugs (AEDs) used in combination with VNS (vagus nerve stimulation) Therapy does not cause a "rebound" increase in seizure rates, according to a study presented at a...

Studies: CellCept benefits patients reinfected with after liver transplant.(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- The immunosuppressive drug CellCept (mycophenolate mofetil) positively altered the course of hepatitis C reinfection after liver transplantations in three investigational studies reported at the...

MelTec studies describe protein networks involved in T-cell invasion.(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- MelTec GmbH, a functional proteomics company, announced the publication of two scientific studies in the April 2002 issue of the Journal of Theoretical Medicine, describing the protein networks involved...

Prograf plus rapamycin: Combined use safe and effective.(Brief Article)
June 5, 2002... 2002 JUN 5 - (NewsRx.com & NewsRx.net) -- Prograf (tacrolimus) can be used safely in combination with the new, adjunctive immunosuppressant, rapamycin, according to results announced at the American Transplant Congress meeting . ...

Experimental therapy stops allergic reactions in mice.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) have devised a new, experimental approach to treating allergic diseases. In mice, the scientists used a...

Humoral immune activity important for (gamma)-herpesvirus control.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have proposed a novel form of preventive treatment for patients with latent (gamma)-herpesvirus infections. "The human...

Targeted vaccine may help immune system fight cancer.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Completing an important step in the evaluation of a cancer vaccine that has the potential to selectively target a wide range of tumors, researchers at the Ludwig Institute for Cancer Research report...

Encapsulated vaccine more effective than vaccine suspensions for reducing tumor burden.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - When used preoperatively or early postoperatively for murine colorectal cancer, an encapsulated whole-cell plus adjuvant vaccine significantly...

Older B cells in elderly don't fight infection as well.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- New research on cells that produce disease-fighting antibodies helps explain why people succumb more easily to infectious diseases as they grow older. Researchers at National Jewish Medical and...

Mice could provide the key to growing human lungs for transplant.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Scientists from Imperial College London have successfully directed mouse stem cells to turn into the type of cells needed for gas exchange in lungs, bringing the prospect of being able to regenerate...

Preclinical study shows AGI-1096 decreases graft narrowing associated with transplant rejection.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX) announced that the results of a preclinical study support the effectiveness of novel v-protectant, AGI-1096, to decrease the incidence of graft narrowing in preclinical...

New data supporting company's technology platform presented.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO.TO, ALXFF.OTC) made an oral presentation at the Experimental Biology 2002 conference in New Orleans, an American Association of Immunology sponsored event. Birgit Schultes, PhD,...

Roy First, MD to join Fujisawa's immunology group.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Fujisawa Healthcare, Inc. announced the appointment of Roy First, MD, as medical director for its transplantation and immunology products. First currently serves as professor of medicine, director,...

Ascension receives FDA approval for PIP PyroCarbon implant.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Ascension Orthopedics, Inc., has received U.S. Food and Drug Administration (FDA) approval to market the Ascension PIP PyroCarbon Total Joint within the United States. This is the second...

Black, Latino children get lesser care.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Even when Medicaid will pay the cost, many black and Latino children with asthma are not receiving appropriate preventive medications for their condition - and white children covered by Medicaid are...

Dynavax initiates first human trial of ISS for Asthma.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Dynavax Technologies, a privately held biopharmaceutical company, announced it has initiated a phase I clinical study to evaluate the safety and tolerability of its inhaled ISS (immunostimulatory DNA...

Treating seasonal allergies early keeps children healthy now, in future.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Treating allergic rhinitis as soon as symptoms occur can help children do better in school and could prevent longterm complications, such as the development of asthma or earaches, according to the...

Johns Hopkins and CEL-SCI scientists present results in autoimmune disease research.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Scientists from the laboratory of Dr. Noel Rose in The Johns Hopkins University department of pathology and CEL-SCI Corp. (CVM) presented data at the Experimental Biology 2002 meeting that could lead...

Companies sign exclusive license agreement to develop five monoclonal antibodies.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO.TO, ALXFF.OTC) announced that AltaRex and a wholly owned subsidiary of United Therapeutics Corp. have entered into an exclusive license agreement for the development of five...

Company highlights pharmaceutical product developments at annual meeting.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- At the annual meeting of Abbott Laboratories (ABT) shareholders, chairman and CEO Miles D. White highlighted the company's scientific efforts; the successful integration of Knoll; and the performance...

First quarter net loss: $0.09 per share.(Epimmune Inc.)(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN), a biotechnology company focused on the development of pharmaceutical products using multiple, specific epitopes to activate the body's immune system, announced its financial...

Company reveals new aspects of mechanism of action for HspE7.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Stressgen Biotechnologies Corporation (SSB) presented new research results, which further validate the company's mechanism of action for its patented heat shock protein (Hsp) fusion platform technology...

Sepsis on the increase in U.S., according to Emory University and CDC study.(Disease Control and Prevention)(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- The incidence of sepsis - a severe, whole-body immune response to infection - is increasing by an average of 16% a year in the U.S., according to research by investigators at Emory University School of...

Dimethaid Research completes purchase agreement for Oxo Chemie AG.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Dimethaid Research, Inc., announced that it has completed the agreement to acquire Oxo Chemie AG of Switzerland. This US$36.96 million acquisition will expand its existing product pipeline to...

Long-term survival data in phase II trial of GVAX vaccine reported at conference.(Brief Article)
June 12, 2002... 2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Cell Genesys, Inc. (CEGE) has reported encouraging long-term survival data from a phase II multicenter clinical trial of GVAX prostate cancer vaccine which demonstrates a dose-dependent trend toward...

BCG inoculation does not protect against asthma.
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Bacillus Calmette-Guerin (BGC) vaccination to prevent tuberculosis infection did not confer protection against asthma scientists in Norway report....

U-M study finds new target in war against graft-versus-host disease.
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- University of Michigan (U-M) scientists have discovered how graft-versus-host disease (GvHD), a common and deadly complication of life-saving bone marrow transplants, attacks and often kills its...

Researchers create functional tissue in cows.(therapeutic cloning research)
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- In a study published in the July 2002 issue of Nature Biotechnology, now available online, researchers from Children's Hospital Boston and colleagues demonstrate that laboratory-engineered tissues...

Healthcare providers miss many opportunities to vaccinate children.
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- by Roxanne Nelson, medical writer - Self reporting of immunization procedures and actual clinical practice do not always correlate, researchers in the U.S. say. Pediatric healthcare practitioners may...

Natural inhibitor endostatin could be effective for treating arthritic disease.
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - People who must deal with the pain and debilitative effects of rheumatoid arthritis could see some therapeutic benefits from receiving endostatin therapy. ...

Studies add to debate over arthritis drugs.
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- Three new studies that didn't involve the popular arthritis pill Vioxx nonetheless add to the debate over whether it increases heart attack risks. The editor of Archives of Internal Medicine, which...

Tanox names Jeffrey Organ chief operating officer.(Brief Article)
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- Tanox (TNOX), a biopharmaceutical company focused on the discovery and development of therapeutic monoclonal antibodies designed to address allergy, asthma, and immune system diseases, has announced...

Higher rates among African Americans linked to low birth weight.(asthma prevalence)
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- Investigators have found a correlation between low birth weight (weighing less that 5 pounds, 8 ounces at birth) and higher prevalence of asthma among African Americans in a study published in the...

Interleukin-12 blocks stem cell eosinophil differentiation.
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have shed new light on the mechanisms by which the cytokine interleukin (IL)-12 relieves the symptoms of asthma. ...

Sunesis, Johnson & Johnson collaborate to discover new small molecule therapeutics.(Brief Article)
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- Sunesis Pharmaceuticals, Inc., announced that the company has entered into a research collaboration with Johnson & Johnson Pharmaceutical Research & Development, LLC, to discover small molecule enzyme...

Cambridge Antibody reports interim results on several trials.(Cambridge Antibody Technology Group PLC)
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- Cambridge Antibody Technology (CAT) has released interim results of several monoclonal antibody studies underway. Professor Peter Garland, CAT's chairman, said, "In the first 6 months of the year...

Study: Two-dose Zenapax reduced incidence of acute organ rejection.
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- Two doses of the immunosuppressive agent Zenapax (daclizumab) decreased rejection in kidney transplant patients at high risk for delayed organ function, and had cost benefits when compared with OKT3...

Medarex acquires antibody payload technology and product development programs.(Brief Article)
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- Medarex, Inc., (MEDX) and Corixa Corp. (CRXA) announced that Medarex has acquired Corixa's proprietary Ultra-Potent Toxin technology for creating antibody-toxin conjugates and certain preclinical...

MetaMorphix announces three new patents.
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- MetaMorphix, Inc., announced that the U.S. Patent and Trademark Office has taken positive action on three patents directed to its Myostatin technology, a potent and highly specific regulator of...

Cell Genesys reports encouraging long-term survival data in phase II trial.
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- Cell Genesys, Inc. (CEGE) reported encouraging long-term survival data from a phase II multicenter clinical trial of GVAX prostate cancer vaccine, which demonstrates a dose-dependent trend toward...

More evidence that periodontitis may be a risk factor for heart disease.
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- Cardiac transplant patients had a significantly higher incidence of periodontal disease than patients with no history of heart disease involved in a recent study, according to data presented today at...

New transplant organ sensor technology developed.
June 19, 2002... 2002 JUN 19 - (NewsRx.com & NewsRx.net) -- Scientists at the University of Ulster have unveiled a monitoring system that can ensure transplant organs arrive in pristine condition for the life-saving surgery. They have developed tiny...

Consensus interferon may work when other regimens are ineffective.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Genetically modified interferon (IFN), known as consensus interferon, may offer new hope to patients with chronic hepatitis C whose disease fails to respond to...

Mixing diphtheria-tetanus-acellular pertussis vaccines (DTaP) from different manufacturers is safe and effective.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Infants who received diphtheria-tetanus-acellular pertussis vaccines (DTaP) produced by two different manufacturers did not experience elevated...

Attenuated infection can create powerful antiviral T cells.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in New York have developed a novel immunotherapy technique for preventing and treating HIV infection. Dr. Malgorzata Simm and colleagues at...

Keeping autoimmunity in check may depend on balance in the immune system.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- Scientists know that the potential to generate dangerous antibodies that attack our own cells and tissues - one of the defining characteristics of autoimmune disorders like lupus - exists in everyone....

Technique allows researchers to watch immune system recognize foreign invaders.(fluorescence resonance energy transfer )(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- Using a new technique that allows scientists to see the internal machinery of a living cell, a team of researchers addressed one of the most fundamental issues in immune research - the early events in...

Dendritic cell yields can be improved in culture.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Japan have found a way to improve the amount of antigen-presenting cells derived from hematopoietic stem cell cultures. Dr. Aichun Liu and...

Study yields new clues on body's rejection of transplanted organs.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- A new method for tracking immune cell activity in mice could lead to new drugs for preventing organ rejection, according to a new study from the Department of Veterans Affairs (VA), and Yale and Emory...

DC-SIGN could be therapeutic target.(dendritic cell-specific ICAM-3 grabbing nonintegrin)(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Spain say that they may have found a novel target for immnotherapy against HIV infection. "Dendritic cell-specific ICAM-3 grabbing...

Herpes simplex vectors can enhance immunogenecity.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Herpes simplex-based vectors may be the best choice for antigen delivery by HIV vaccines, researchers report. "Herpes simplex virus type 1 (HSV-1) infects...

Vaccine shows promise in early research.(brain cancer)(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- An experimental vaccine for brain cancer has shown promising results in preliminary investigations at the University of California Los Angeles Jonsson Cancer Center. The results are published in...

Company reports 17.7% sales increase in the first quarter.(Abbott Laboratories )(Brief Article)(Statistical Data Included)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories reported increases in both sales and earnings for the first quarter of 2002. The company also announced that it had submitted U.S. and European regulatory packages to the FDA...

Toxin Alert receives two U.S. patents.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- Toxin Alert, Inc., announced the issuance of two additional U.S. patents on its Toxin Guard technology. U.S. Patent No. 6,376,204 was issued April 23, 2002, and U.S. Patent No. 6,379,908 was issued...

Protection against malaria, herpes, and cancer reported with new peptide.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- Cel-Sci Corp. (CVM) and the Naval Medical Research Center (NMRC) announced that a newly discovered peptide provided 100% protection against malaria infection in a mouse model. Dr. Yupin Charoenvit...

Wyeth Pharmaceuticals: New Rapamune tablet could increase convenience for patients.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- New Rapamune (sirolimus) Tablet could bring greater convenience to kidney transplant patients. Following marketing authorization from the European Commission, Wyeth Pharmaceuticals is launching a...

Studies: Long-term use CellCept lowers rejection risk.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- Long-term (greater or equal to 1 year) use of CellCept (mycophenolate mofetil) reduced the incidence and risk of late rejection of kidney transplants compared with azathioprine, even in high-risk...

Adult cells can reinvent themselves.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- A team of scientists from Norway has succeeded in coaxing one type of cultured adult cell to start behaving like a completely different type of adult cell. Their approach will aid scientists...

Study confirms seasonal fluctuation in immunity-generating cells.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- Through a first-ever longitudinal study, researchers have confirmed that T-cells show seasonal fluctuation in multiple sclerosis (MS) patients, and that the T-cells were at a high in the autumn months....

Berna and Iomai announce collaboration for patch delivery of vaccines.(Berna Biotech Ltd.)(Iomai Corp.)(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- Berna Biotech, Ltd., (BBIN) and Iomai Corp., a private biopharmaceutical company, announced a collaboration for the development of vaccines for administration using a skin patch. The collaboration...

Nova BioGenetics receives China's approval for antimicrobial hand gel.(BioShield Technologies Inc.)(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- BioShield Technologies, Inc., (BSTI) announced that Nova BioGenetics, an affiliate company of BioShield, has recently received approval from the Chinese Department of Health for the country's first...

eXegenics creates new antibacterial agent.(eXegnics Inc.)(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- eXegenics, Inc., (EXEG), a postgenomics drug creation company, announced that the company has created a new class of antibacterial agents specific to certain pathogenic bacteria. The company also...

Abbott seeks U.S. and European regulatory approvals for adalimumab.(Abbott Laboratories)(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) announced that it has simultaneously submitted a Biologic License Application (BLA) to the U.S. Food and Drug Administration (FDA) and a Marketing Authorization Application...

Pilot project with genomics collaborative to pursue inflammatory disease treatments.(Genomics Collaborative Inc.)(AnVil)(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- In a move to accelerate the development of new rheumatoid arthritis drugs, life sciences pioneer AnVil announced a pilot project with Genomics Collaborative, Inc., (GCI) of Cambridge, Massachusetts, to...

Graft-versus-host prophylaxis improves outcome with depleted grafts.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Extensive graft-versus-host prophylaxis is needed to ensure maximal benefit from T cell-depleted stem cell grafts, researchers in the United States argue. ...

Mannose-binding lectin replacement may reduce morbidity risk.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Australia have identified a novel target for treatments aimed at preventing morbidity after hematopoietic stem cell transplantation. ...

Photodynamic graft purging helps prevent graft-versus-host reactions.(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in North Carolina have developed a novel technique for selectively removing dangerous T cells from stem cell grafts. Dr. Benny J. Chen and...

La Jolla reports new data on antibody-mediated thrombosis.(La Jolla Pharmaceutical Co.)(Brief Article)
June 26, 2002... 2002 JUN 26 - (NewsRx.com & NewsRx.net) -- La Jolla Pharmaceutical Co. (LJPC) presented data supportive of its investigational drug candidate LJP 1082 for the treatment of antibody-mediated thrombosis, a life-threatening blood-clotting disorder...